Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 7Prostatic Neoplasms 6Hematopoietic and Lymphatic System Neoplasm 6Hematologic Neoplasms 6Colorectal Neoplasms 5Breast Neoplasms 5Anatomic Stage I Breast Cancer AJCC v8 5Pancreatic Neoplasms 3Neoplasms 3Malignant Solid Neoplasm 3Leukemia, Myeloid, Acute 3Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Mouth Neoplasms 2Melanoma 2Head and Neck Carcinoma 2Glioma 2Carcinoma, Renal Cell 2Carcinoma 2COVID-19 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urologic Diseases 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tonsillar Neoplasms 1Tongue Neoplasms 1Teratoma 1

Interventions

Etoposide 3fludarabine phosphate 2fludarabine 2Cyclophosphamide 2Carboplatin 2repotrectinib 1pembrolizumab 1lutetium Lu 177 dotatate 1Vorinostat 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Paclitaxel 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Ifosfamide 1Cytapheresis 1Cisplatin 1Bleomycin 1Biopsy 1Automobiles 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Practice Guidelines as Topic × 90 days × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡